Table 3. Differential expression results for CRISPLD2 obtained from publicly available data of two previous microarray studies that investigated the effects of GCs on human ASM cells.
Study | Comparison Group | Rank | Adjusted P-value | Fold Change |
GSE34313 | 4 hr DEX vs. baseline | 305 | 5.1E-05 | 1.85 |
GSE34313 | 24 hr DEX vs. baseline | 850 | 8.3E-06 | 1.95 |
GSE13168 | Fluticasone vs. basal | 6 | 3.9E-07 | 6.09 |
GSE13168 | Fluticasone+EGF vs. EGF | 4 | 2.4E-05 | 4.33 |
GSE13168 | Fluticasone+IL1β vs. IL1β | 45 | 1.5E-03 | 2.78 |
GSE13168 | Fluticasone+EGF+IL1β vs. EGF+IL1β | 68 | 3.9E-02 | 2.13 |
Rank refers to ranking within all differentially expressed genes of each comparison group.